{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T13:05:48Z","timestamp":1789477548699,"version":"build-2803163510"},"reference-count":63,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>WWP2 is a NEDD4-family HECT E3 ubiquitin ligase with emerging relevance to immune regulation and cancer immunity. Although WWP2 has been widely studied in tumor growth, fibrosis, and cell signaling, its immune functions are less consistently integrated into current models of cancer immune surveillance. This review summarizes the structural and regulatory features of WWP2 and examines how its substrate- and adaptor-dependent activities influence B cell tolerance, helper T cell responses, innate immune signaling, and tumor immune escape. Particular attention is given to the SUSD6\/TMEM127\/WWP2 axis, which promotes MHC-I ubiquitination and lysosomal degradation, thereby reducing cell-surface antigen presentation and potentially weakening cytotoxic T cell recognition. By separating immune, tumor-intrinsic, and context-specific mechanisms, we highlight WWP2 as a conditional regulator of antigen presentation rather than a uniformly oncogenic ligase. A more precise understanding of WWP2-dependent immune pathways may support biomarker development and guide therapeutic strategies that restore antigen presentation or selectively disrupt pathogenic adaptor-ligase interactions.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1966504","type":"journal-article","created":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T12:16:27Z","timestamp":1789474587000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["WWP2 in immune surveillance and antigen presentation: context-dependent roles in B cells, T cells, and tumor immune escape"],"prefix":"10.3389","volume":"17","author":[{"given":"Wanchen","family":"Lu","sequence":"first","affiliation":[{"name":"Department of Pathology, The First Hospital of China Medical University","place":["Shenyang, Liaoning, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinan","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Pathology, The First Hospital of China Medical University","place":["Shenyang, Liaoning, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyan","family":"Xi","sequence":"additional","affiliation":[{"name":"Department of Pathology, The First Hospital of China Medical University","place":["Shenyang, Liaoning, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuyong","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Pathology, The First Hospital of China Medical University","place":["Shenyang, Liaoning, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3739","article-title":"Ubiquitination in disease pathogenesis and treatment","volume":"20","author":"Popovic","year":"2014","journal-title":"Nat Med"},{"key":"B2","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/cr.2016.39","article-title":"Ubiquitin modifications","volume":"26","author":"Swatek","year":"2016","journal-title":"Cell Res"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-biochem-060815-014922","article-title":"Ubiquitin ligases: structure, function, and regulation","volume":"86","author":"Zheng","year":"2017","journal-title":"Annu Rev Biochem"},{"key":"B4","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/nri3111","article-title":"The role of ubiquitylation in immune defence and pathogen evasion","volume":"12","author":"Jiang","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.bbamcr.2013.03.024","article-title":"Mammalian HECT ubiquitin-protein ligases: biological and pathophysiological aspects","volume":"1843","author":"Scheffner","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"B6","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/nrm2690","article-title":"Physiological functions of the HECT family of ubiquitin ligases","volume":"10","author":"Rotin","year":"2009","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1006\/mcne.1998.0677","article-title":"Atrophin-1, the DRPLA gene product, interacts with two families of WW domain-containing proteins","volume":"11","author":"Wood","year":"1998","journal-title":"Mol Cell Neurosci"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1107\/s2053230x1501554x","article-title":"Structure of the HECT domain of human WWP2","volume":"71","author":"Gong","year":"2015","journal-title":"Acta Crystallogr F Struct Biol Commun"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.febslet.2015.05.021","article-title":"Characterization of substrate binding of the WW domains in human WWP2 protein","volume":"589","author":"Jiang","year":"2015","journal-title":"FEBS Lett"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-018-0026-1","article-title":"Activity-based E3 ligase profiling uncovers an E3 ligase with esterification activity","volume":"556","author":"Pao","year":"2018","journal-title":"Nature"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.ra119.009211","article-title":"Comparative analysis of the catalytic regulation of NEDD4-1 and WWP2 ubiquitin ligases","volume":"294","author":"Jiang","year":"2019","journal-title":"J Biol Chem"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2010.617","article-title":"Selective targeting of activating and inhibitory Smads by distinct WWP2 ubiquitin ligase isoforms differentially modulates TGF-beta signalling and EMT","volume":"30","author":"Soond","year":"2011","journal-title":"Oncogene"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2013.08.001","article-title":"Novel WWP2 ubiquitin ligase isoforms as potential prognostic markers and molecular targets in cancer","volume":"1832","author":"Soond","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"B14","doi-asserted-by":"publisher","first-page":"3616","DOI":"10.1038\/s41467-019-11551-9","article-title":"WWP2 regulates pathological cardiac fibrosis by modulating SMAD2 signaling","volume":"10","author":"Chen","year":"2019","journal-title":"Nat Commun"},{"key":"B15","doi-asserted-by":"publisher","first-page":"7375","DOI":"10.1038\/s41467-022-34971-6","article-title":"The E3 ubiquitin ligase WWP2 regulates pro-fibrogenic monocyte infiltration and activity in heart fibrosis","volume":"13","author":"Chen","year":"2022","journal-title":"Nat Commun"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/s41418-020-0523-2","article-title":"Selective targeting of ubiquitination and degradation of PARP1 by E3 ubiquitin ligase WWP2 regulates isoproterenol-induced cardiac remodeling","volume":"27","author":"Zhang","year":"2020","journal-title":"Cell Death Differ"},{"key":"B17","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s12933-023-01818-3","article-title":"Down-regulation of WWP2 aggravates type 2 diabetes mellitus-induced vascular endothelial injury through modulating ubiquitination and degradation of DDX3X","volume":"22","author":"You","year":"2023","journal-title":"Cardiovasc Diabetol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.18632\/oncoscience.101","article-title":"WWP2 is overexpressed in human oral cancer, determining tumor size and poor prognosis in patients: downregulation of WWP2 inhibits AKT signaling and tumor growth in mice","volume":"1","author":"Fukumoto","year":"2014","journal-title":"Oncoscience"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.gore.2015.05.004","article-title":"WWP2 and its association with PTEN in endometrial cancer","volume":"13","author":"Clements","year":"2015","journal-title":"Gynecol Oncol Rep"},{"key":"B20","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s12964-023-01050-2","article-title":"WWP2 drives the progression of gastric cancer by facilitating the ubiquitination and degradation of LATS1 protein","volume":"21","author":"Zou","year":"2023","journal-title":"Cell Commun Signal"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1002\/cbin.11856","article-title":"WWP2 overexpression inhibits the antitumor effects of doxorubicin in hepatocellular carcinoma","volume":"46","author":"Qin","year":"2022","journal-title":"Cell Biol Int"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2206694120","article-title":"lncRNA BREA2 promotes metastasis by disrupting the WWP2-mediated ubiquitination of Notch1","volume":"120","author":"Zhang","year":"2023","journal-title":"Proc Natl Acad Sci USA"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1220271110","article-title":"E3 ligase WWP2 negatively regulates TLR3-mediated innate immune response by targeting TRIF for ubiquitination and degradation","volume":"110","author":"Yang","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-018-0137-8","article-title":"The E3 ligases Itch and WWP2 cooperate to limit TH2 differentiation by enhancing signaling through the TCR","volume":"19","author":"Aki","year":"2018","journal-title":"Nat Immunol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1038\/s41467-025-67665-w","article-title":"The E3 ligases Itch and WWP2 regulate autoimmune neuroinflammation by controlling TH2 to TH17 cell conversion via interleukin-4-STAT5 axis in mice","volume":"17","author":"Zhao","year":"2026","journal-title":"Nat Commun"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2205629119","article-title":"LAPTM5 mediates immature B cell apoptosis and B cell tolerance by regulating the WWP2-PTEN-AKT pathway","volume":"119","author":"Wang","year":"2022","journal-title":"Proc Natl Acad Sci USA"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2025.111838","article-title":"Evolutionary conserved regulation of TFEB stability by the E3 ubiquitin ligase WWP2 modulates response to stress in vivo","volume":"28","author":"Garcia-Sanchez","year":"2025","journal-title":"iScience"},{"key":"B28","doi-asserted-by":"publisher","first-page":"3903","DOI":"10.1016\/j.cell.2023.07.016","article-title":"A membrane-associated MHC-I inhibitory axis for cancer immune evasion","volume":"186","author":"Chen","year":"2023","journal-title":"Cell"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1126\/science.1203486","article-title":"Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion","volume":"331","author":"Schreiber","year":"2011","journal-title":"Science"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.immuni.2013.07.012","article-title":"Oncology meets immunology: the cancer-immunity cycle","volume":"39","author":"Chen","year":"2013","journal-title":"Immunity"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2004.07.017","article-title":"The immunobiology of cancer immunosurveillance and immunoediting","volume":"21","author":"Dunn","year":"2004","journal-title":"Immunity"},{"key":"B32","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.coi.2015.12.007","article-title":"The urgent need to recover MHC class I in cancers for effective immunotherapy","volume":"39","author":"Garrido","year":"2016","journal-title":"Curr Opin Immunol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/s41568-021-00339-z","article-title":"Antigen presentation in cancer: insights into tumour immunogenicity and immune evasion","volume":"21","author":"Jhunjhunwala","year":"2021","journal-title":"Nat Rev Cancer"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.636568","article-title":"Cancer immune evasion through loss of MHC class I antigen presentation","volume":"12","author":"DhatChinamoorthy","year":"2021","journal-title":"Front Immunol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2023.102329","article-title":"Tumor immune evasion through loss of MHC class-I antigen presentation","volume":"83","author":"Sari","year":"2023","journal-title":"Curr Opin Immunol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.molimm.2017.12.005","article-title":"The regulatory network behind MHC class I expression","volume":"113","author":"Jongsma","year":"2019","journal-title":"Mol Immunol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12071760","article-title":"MHC class I downregulation in cancer: underlying mechanisms and potential targets for cancer immunotherapy","volume":"12","author":"Cornel","year":"2020","journal-title":"Cancers (Basel)"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.844866","article-title":"Mechanisms of MHC-I downregulation and role in immunotherapy response","volume":"13","author":"Taylor","year":"2022","journal-title":"Front Immunol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"5999","DOI":"10.1073\/pnas.1602069113","article-title":"NLRC5\/MHC class I transactivator is a target for immune evasion in cancer","volume":"113","author":"Yoshihama","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3390\/cells10123309","article-title":"Potential of E3 ubiquitin ligases in cancer immunity: opportunities and challenges","volume":"10","author":"Ye","year":"2021","journal-title":"Cells"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1039\/d2cs00193d","article-title":"PROTACs: past, present and future","volume":"51","author":"Li","year":"2022","journal-title":"Chem Soc Rev"},{"key":"B42","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/s41573-021-00371-6","article-title":"PROTAC targeted protein degraders: the past is prologue","volume":"21","author":"Bekes","year":"2022","journal-title":"Nat Rev Drug Discov"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1038\/nature25501","article-title":"TGF-beta attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells","volume":"554","author":"Mariathasan","year":"2018","journal-title":"Nature"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1038\/nature25492","article-title":"TGF-beta drives immune evasion in genetically reconstituted colon cancer metastasis","volume":"554","author":"Tauriello","year":"2018","journal-title":"Nature"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-00490-y","article-title":"Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity","volume":"21","author":"Veglia","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-019-0127-6","article-title":"Macrophages as regulators of tumour immunity and immunotherapy","volume":"19","author":"DeNardo","year":"2019","journal-title":"Nat Rev Immunol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0014-x","article-title":"Understanding the tumor immune microenvironment for effective therapy","volume":"24","author":"Binnewies","year":"2018","journal-title":"Nat Med"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.01.017","article-title":"Primary, adaptive, and acquired resistance to cancer immunotherapy","volume":"168","author":"Sharma","year":"2017","journal-title":"Cell"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1126\/science.aar4060","article-title":"Cancer immunotherapy using checkpoint blockade","volume":"359","author":"Ribas","year":"2018","journal-title":"Science"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-021-00574-3","article-title":"CD8+ T cell differentiation and dysfunction in cancer","volume":"22","author":"Philip","year":"2022","journal-title":"Nat Rev Immunol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2018.03.012","article-title":"T cell dysfunction in cancer","volume":"33","author":"Thommen","year":"2018","journal-title":"Cancer Cell"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1038\/s44318-024-00319-7","article-title":"Hypoxia promotes tumor immune evasion by suppressing MHC-I expression and antigen presentation","volume":"44","author":"Estephan","year":"2025","journal-title":"EMBO J"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2025.110847","article-title":"Mammalian and bacterial adaptors function as co-disinhibitory pairs to activate the E3 ubiquitin ligase WWP2","volume":"301","author":"Blundell","year":"2025","journal-title":"J Biol Chem"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1004751","article-title":"Notch3 interactome analysis identified WWP2 as a negative regulator of Notch3 signaling in ovarian cancer","volume":"10","author":"Jung","year":"2014","journal-title":"PloS Genet"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00080.2002","article-title":"Ubiquitin-protein ligase WWP2 binds to and downregulates the epithelial Na+ channel","volume":"283","author":"McDonald","year":"2002","journal-title":"Am J Physiol Renal Physiol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1101\/gad.321943.118","article-title":"WWP2 ubiquitylates RNA polymerase II for DNA-PK-dependent transcription arrest and repair at DNA breaks","volume":"33","author":"Caron","year":"2019","journal-title":"Genes Dev"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1128\/mcb.01667-06","article-title":"Wwp2-mediated ubiquitination of the RNA polymerase II large subunit in mouse embryonic pluripotent stem cells","volume":"27","author":"Li","year":"2007","journal-title":"Mol Cell Biol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1038\/emboj.2011.303","article-title":"Pin1 and WWP2 regulate GluR2 Q\/R site RNA editing by ADAR2 with opposing effects","volume":"30","author":"Marcucci","year":"2011","journal-title":"EMBO J"},{"key":"B59","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/s41419-025-08318-0","article-title":"WWP2-induced inhibition of hepatocellular carcinoma cellular senescence via the ubiquitination and degradation of p21","volume":"17","author":"Chen","year":"2026","journal-title":"Cell Death Dis"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2024.101257","article-title":"E3 ubiquitin ligase WWP2 as a promising therapeutic target for diverse human diseases","volume":"96","author":"You","year":"2024","journal-title":"Mol Aspects Med"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1120710","article-title":"E3-ubiquitin ligases and recent progress in osteoimmunology","volume":"14","author":"Asano","year":"2023","journal-title":"Front Immunol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1038\/embor.2009.30","article-title":"Control of the activity of WW-HECT domain E3 ubiquitin ligases by NDFIP proteins","volume":"10","author":"Mund","year":"2009","journal-title":"EMBO Rep"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0911714107","article-title":"Regulation of PTEN\/Akt and MAP kinase signaling pathways by the ubiquitin ligase activators Ndfip1 and Ndfip2","volume":"107","author":"Mund","year":"2010","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1966504\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T12:16:28Z","timestamp":1789474588000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1966504\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,15]]},"references-count":63,"alternative-id":["10.3389\/fimmu.2026.1966504"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1966504","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,15]]},"article-number":"1966504"}}